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SIMCovalent posttranslational modiﬁcation with SUMO (small ubiquitin-related modiﬁer) modulates functions of a
wide range of proteins in eukaryotic cells. Sumoylation affects the activity, interaction properties, subcellular lo-
calization and the stability of its substrate proteins. The recent discovery of a novel class of ubiquitin ligases (E3),
termed ULS (E3-S) or STUbL, that recognize sumoylated proteins, links SUMO modiﬁcation to the ubiquitin/
proteasome system. Here we review recent insights into the properties and function of these ligases and their
roles in regulating sumoylated proteins. This article is part of a Special Issue entitled: Ubiquitin–Proteasome
System. Guest Editors: Thomas Sommer and Dieter H. Wolf.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY license.1. Introduction
Covalent conjugation of the ubiquitin-related modiﬁer SUMO to
other proteins (termed sumoylation) is a posttranslational protein
modiﬁcation with essential functions in most eukaryotes [1,2]. A
known exception is the ﬁssion yeast Schizosaccharomyces pombe, in
which deletion of the SUMO encoding gene pmt3 is not lethal. Mu-
tants lacking pmt3, however, grow poorly and display genome insta-
bility [3]. While organisms ranging from yeasts to invertebrates
express only a single SUMO type, plant and mammalian cells express
multiple SUMO isoforms [4,5]. Sumoylation of proteins changes their
interaction properties in various ways leading to alterations in their
subcellular localization, their function and/or stability [6]. SUMO
modiﬁcation has important functions in many cellular processes
ranging from DNA damage control to the regulation of mitochondrial
dynamics [6,7]. The SUMO protein modiﬁcation system intersects
and interacts with the modiﬁcation system for its relative ubiquitin
in many ways (see references [8,9] for broader reviews on this
subject). One such intersection is that sumoylation serves as a recog-
nition signal for a class of ubiquitin ligases to which this review is
devoted.itin–Proteasome System. Guest
).
. Open access under CC BY license.2. The SUMO system
Conjugation of SUMO to its substrates involves anenzymatic cascade
comprising SUMO-activating enzyme, the SUMO conjugating enzyme,
and one of several SUMO ligases [10]. Conjugation of SUMO to an inter-
nal lysine (K) residue of another SUMO can lead to the formation of
substrate-attached SUMO chains (poly-sumoylation) [11,12].
The ability to form SUMO chains varies between SUMO isoforms and
occurs preferentially with SUMO isoforms bearing lysine (K) residues
within ΨKxD/E consensus motifs (Ψ is a hydrophobic residue such as
I, V, or L) located in their N-terminal domains. Saccharomyces cerevisiae
SUMO (also called Smt3) has three such lysine residues (K11, K15, and
K19), whereas the nearly identical human SUMO2 and SUMO3 (only
three residues difference), as well as SUMO4, have only one such resi-
due (K11) [11,12]. SUMO1 lacks a Lys residue in such a consensus
motif and therefore does not form chains efﬁciently [11], although for-
mation of SUMO1 chains has been observed in vitro [13–15]. Because
of itself being a poor sumoylation substrate, SUMO1 is considered to
act as a chain terminator upon its conjugation to SUMO2/3 chains
[16].While SUMO-SUMO linkages involving the consensus sumoylation
site K11 of SUMO2/3 are the most abundant ones, proteomic analyses
identiﬁed other Lys residues of SUMO1 and SUMO2/3 as additional ac-
ceptor sites, suggesting that chain topology may be a more complex
issue [15,17–22]. The signiﬁcance of SUMO4 conjugation, and a possible
role in chain formation, is still not much explored. A mutation of this
SUMO isoform was identiﬁed as a factor associated with susceptibility
to type 1 diabetes [23]. Because SUMO4 bears a proline residue at posi-
tion 90, the SUMO4precursor is apparently not or only poorly processed
under standard culture conditions [24]. Stress imposedby serum starva-
tion, however, was reported to induce processing of SUMO4 and its
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lysine residue suggests that mature SUMO4 is likely to form chains
in vivo. Consistent with this assumption, a link between SUMO3 and
K11 of SUMO4 has been identiﬁed in a proteomic approach [22]. It is
an interesting question whether SUMO4 chains, because of Pro-90, are
more resistant to chain de-polymerizing SUMO-speciﬁc isopeptidases
and therefore possibly a prominent feature of SUMO4 conjugates.
SUMO proteinmodiﬁcation is reversible [26,27]. Single SUMOmoie-
ties or SUMO chains can be deconjugated by SUMO isopeptidases
(termed ULP, SENP or SUSP), which therefore, aside from the enzymes
controlling SUMO conjugation, fulﬁll important roles in controlling the
sumoylation state of proteins (see references [28–31] for reviews on
this subject). The Ulp2 protein in S. cerevisiae, as well as its closest rela-
tives in mammals, Senp6 (also known as Susp1) and Senp7, appear to
provide themain SUMO chain depolymerizing activities in these organ-
isms [12,32,33].
SUMO chains have been implicated in the response to replication ar-
rest and various forms of stress, as well as in a variety of other cellular
functions [34–39]. They serve as targeting signals recognized by mem-
bers of a novel class of ubiquitin ligases termed SUMO-targeted
ubiquitin ligases (STUbL) or ubiquitin ligases (E3) for sumoylated
proteins (ULS, E3-S) [40–44]. As discussed in more detail below, it is
one function of ULS-mediated ubiquitylation of sumoylated proteins
to target them for degradation by the proteasome. ULSs thus contribute
an additional regulatory mechanism to the control of the levels of
sumoylated forms of a substrate. In other cases, ULSs appear to generate
a novel composite binding motif recognized by tandem ubiquitin and
SUMO interactionmotifs. In this review,we have focused on the proper-
ties and function of ULS-type ubiquitin ligases.
3. Properties and functions of ULS enzymes
A number of ULSs were identiﬁed due to their interaction with
SUMO, the presence of SUMO interaction motifs (SIMs), or because
of the sequence similarity between them (Fig. 1). The SIMs were
shown to mediate their preference for sumoylated substrates
[37,40,42,43,45–48]. SIMs are short peptide motifs that can be classi-
ﬁed as SIMa, SIMb, or SIMr according to their exact amino acid se-
quence (Fig. 1). They are usually found in an unstructured context
and are thought to adopt into a short β strand structure which
binds to a grove formed by a β strand and an α helix of SUMO (see
reference [5] for a more detailed discussion). ULSs that have been
functionally dissected thus far combine two features, a RING domain
that mediates interaction with an E2 ubiquitin-conjugating enzyme
and which identiﬁes them as ubiquitin ligases, and SIMs that charac-
terize them as SUMO interactors (Fig. 1). Most of the ULSs studied
thus far bear multiple SIMs, which mediate cooperative binding to
multiple SUMO units thereby providing a preference for substrates
with SUMO chains [40,42].
3.1. ULS enzymes in budding and ﬁssion yeast
Characterization of several yeast ULSs provided the ﬁrst in vivo evi-
dence for the physiological relevance of SUMO-targeted ubiquitylation.
3.1.1. S. cerevisiae Uls1
Uls1 (also known as Ris1/Dis1/Tid4) is one of two RING ﬁnger
ubiquitin ligases identiﬁed as SUMO interacting proteins via two-
hybrid interaction screening [40,45]. Uls1 is a large protein of 1612
amino acids. Its domain structure comprises 4 predicted SIMs in
the N-terminal half, a Swi2/Snf2-like translocase motif in themiddle,
and a RING ﬁnger motif closer to its C-terminus (Fig. 1) [40,45,49,50].
Mutant strains lacking Uls1 accumulate high molecular weight
(HMW) SUMO conjugates. This phenotype is enhanced upon com-
bining uls1Δ with a mutation (slx5Δ) affecting Uls2, the second ULS
identiﬁed in S. cerevisiae, a heterodimer composed of Slx5 and Slx8[40]. Together, these data indicated that Uls1 has overlapping func-
tions with Uls2. However, a direct biochemical proof of ULS activity
is still missing for Uls1, as this large protein has been difﬁcult to pu-
rify. Based upon our in vivo ﬁndings, we proposed that ULSs, such as
Uls1 and Uls2 in yeast, have a function in providing a proteolytic
control of SUMO conjugates (Fig. 2) [40]. The relevance of a link be-
tween SUMO modiﬁcation and the ubiquitin/proteasome system
(UPS) has been underscored by a systems biology study that investi-
gated physical and genetic interaction networks involving SUMO re-
lated functions [51]. Uls1 or uls2 mutations, as well as mutations
affecting the proteasome, for example, were found to cause synthetic
ﬁtness defects when combined with SUMO pathway mutations.
Other components of the UPS were shown to either interact with
SUMO in 2-hybrid assays or to be modiﬁed by sumoylation [51].
The signiﬁcance of the Uls1 Swi2/Snf2 domain can be derived from
genetic data indicating that Uls1 has overlapping functions with
Rdh54 and Rad54, two other Swi2/Snf2-related translocases. Uls1 can
partially substitute for these proteins in DNA damage repair and recom-
bination [52,53]. During double strand break (DSB) repair and recombi-
nation, the RecA-like recombinase Rad51 forms helical ﬁlaments on
single-stranded DNA (ssDNA), which invade the homologous double-
stranded DNA (dsDNA). In the resulting heteroduplex DNA, the homol-
ogous region in the dsDNA can serve as a template for recombinational
damage repair. The Rad51-dsDNA complex has to be dismantled by
Swi2/Snf2-related translocases to allow completion of the repair. In dip-
loid cells, Uls1 appears to contribute to minimizing the toxic accumula-
tion of Rad51-dsDNA complexes in the absence of Rad54 and Rdh54
[52]. A uls1Δmutation was in addition shown to attenuate the toxic ef-
fect of Rad51-dsDNA accumulation that occurs in an sgs1Δmutant. Sgs1
is a helicasewith similarity to Escherichia coli RecQ aswell as the human
WRN and BLM proteins [54]. The data suggest that Uls1 directs
replication-associated lesions into a post-replication repair pathway
that requires a functional Sgs1 helicase [55]. The Swi2/Snf2-type
helicase domain of Uls1 is required for this function. Whether a func-
tional RING ﬁnger or the SIMs of Uls1 are required aswell in this process
has not been investigated as of yet. While the Rad51 protein itself ap-
pears not to be sumoylated, Rad52, the protein that promotes Rad51
loading onto ssDNA, is sumoylated in a DNA damage-inducible manner
[56,57]. A SIM in Rad51 promotes Rad51–Rad52 interaction and Rad51
loading [57]. It was shown that SIMs in the ATP-dependent segregase
Cdc48/p97 and its co-factor Ufd1 play an important role in segregating
sumoylated Rad52 from Rad51 thereby restricting Rad51 levels on
DNA [57]. It will be interesting to see whether SIMs in Uls1 as well con-
tribute to its role in controlling Rad51-dependent processes.
Interestingly, Uls1 was identiﬁed earlier as a yeast two-hybrid
interactor of Dmc1, a meiosis-speciﬁc RecA and Rad51 homolog [50].
During meiotic recombination, Uls1 and Rdh54 speciﬁcally interact
with Dmc1 and dissociate it from bulk chromatin, whereas Rad54 ap-
pears to act speciﬁcally only on Rad51 [52]. It may be worth noting in
this context that formation of SUMO chains have been implicated in
meiosis-speciﬁc processes [58–60]. Again, an interesting question
therefore is whether Uls1 SIMs are required for its function in meiosis.
A recent study has revealed that it is another function of Uls1 to
maintain normal inhibition of non-homologous end joining (NHEJ) at
telomers, which is crucial to prevent the fusion of chromosomal ends
[61]. Evidence reported in this study suggested that Uls1 inhibits NHEJ
of telomers by removing non-functional poly-sumoylated forms of the
Rap1 protein. While unmodiﬁed Rap1 is required to prevent telomere
fusion, this function seems to be impaired by poly-sumoylation of
Rap1. This conclusion is supported by the observations that sumoylation
site mutations in Rap1 and a mutation that inhibits SUMO chain forma-
tion (Smt3-K11,15,19R) bypass the requirement of Uls1 in preventing
telomere fusion [61]. Mutational analysis indicated that both the
translocase and ubiquitin ligase activity of Uls1 are necessary to coun-
teract this effect of poly-sumoylated Rap1. Even though a requirement
of Uls1 SIMs in this process was not demonstrated directly, it was
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from the DNA using its translocase activity, and targets it for
proteasomal degradation using its ubiquitin ligase activity [61].
Uls1 is localized in the nucleolus as well as in the nucleoplasm and
was shown to interact, in a SUMO-dependent manner, with the Ebp2
protein present in the nucleolus [62]. Ebp2 is a yeast homolog of
Epstein–Barr virus nuclear antigen 1-binding protein 2. Ebp2 is impor-
tant formaturation of 25S rRNA and the assembly of 60S ribosomal sub-
units. AnN-terminal SIMof Uls1 is required for its interactionwith Ebp2
[62]. The signiﬁcance of this interaction, whichmight point to a possible
function of Uls1 in ribosome biogenesis, and whether the ubiquitin li-
gase activity is of relevance in this context, remains to be established.
A recent study revealed an interesting direct connection of Uls1with
another ULS enzyme in budding yeast, Uls2 (Slx5–Slx8), the properties
of which are discussed in more detail in the following section. The re-
ported data show that Uls1 binds to Slx5 and negatively regulates its
function [63]. One interesting possibility, that was not addressed in
this study, is that Uls1 competeswith Slx8 for binding to Slx5 and there-
by inhibits Slx5–Slx8 function, possibly by forming an alternative Slx5
complex with a distinct function.
3.1.2. S. cerevisiae Uls2, a Slx5–Slx8 heterodimer
Uls2 was identiﬁed as a second ULS in S. cerevisiae because of its
2-hybrid interaction with SUMO [40,45,46]. Uls2 is a DNA binding
heterodimer formed by the two RING ﬁnger proteins Slx5 and Slx8
[64]. An independent link of this enzyme to the SUMO systemwas pro-
vided by the observation thatmutations in the SLX5 or SLX8 genes wereFig. 1. Schematic representation of SUMO-targeted ubiquitin ligases. Uls1, the heterodimer Slx
Similar to Slx5 in budding yeast, Rfp1 and Rfp2 form complexes with Slx8 in S. pombe. Rnf4 and
molog, ORF61p and Degringolade inDrosophila melanogaster have also been identiﬁed as ULS en
type-r SIMs, and red bars depict non-canonical or proposed SIMs.synthetically lethal with variousmutations affecting SUMO conjugation
[65]. Slx5 (also known as Hex3) bears multiple SIMs of the a- and b-
type, whereas only a single SIMa is present in Slx8 (Fig. 1). This combi-
nation of SIMs enables the binding of HMW-SUMO conjugates, the for-
mation of which involves SUMO chain formation [40,66]. Mutants
lacking Uls2 accumulate such HMW-SUMO conjugates. It appears to
be one important function of Uls2, in cooperation with the E2 enzyme
Ubc4 or its paralog Ubc5, to target poly-sumoylated proteins for degra-
dation by the proteasome [40]. Biochemical evidence indicated that
Slx5–Slx8 preferentially attaches ubiquitin to the terminal SUMOmoie-
ty of a chain [66].
Genetic data link Slx5 and Slx8 to DNA damage repair and genome
stability. SLX5 and SLX8 were originally identiﬁed in a genetic screen
as genes required in a strain lacking the Sgs1 helicase introduced
above [67]. Sgs1mutants show increased rates ofmitotic recombination,
in particular at rDNA repeats, as well as of chromosomemissegregation
(see references [68,69] for recent reviews). They are also impaired in ho-
mologous mitotic and meiotic recombination [70,71]. Mutations in
WRN and BLM, the human homologs of Sgs1, cause premature aging
(Werner's syndrome) or genome instability and cancer (Bloom's syn-
drome), respectively [54]. A functional conservation of these proteins
to yeast Sgs1 is indicated by the observation that the WRN and BLM
genes can complement the hyper-recombination phenotype of sgs1mu-
tants [72]. Defects caused by the inactivation of SGS1 go along with an
accumulation of HMW-SUMO conjugates suggesting that Slx5–Slx8
may have a function in promoting turnover of SUMO-modiﬁed proteins
in the course of, or following DNA repair processes [66]. On the other5/Slx8 (Uls2) and Rad18 have been identiﬁed as ULS or ULS-like enzymes in S. cerevisiae.
Rnf111/Arkadia in humans, Herpes-Simplex Virus ICP0 and its Varicella-Zoster Virus ho-
zymes. The blue bars depict type-a SIMs, green bars depict type-b SIMs, purple bars depict
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absence of Sgs1, and that this lethality is suppressed when SUMO
chain formation is promoted by the inactivation of the Ulp2 SUMO
chain depolymerizing enzyme [67,73]. One plausible explanation for
both observations could be that SUMO-modiﬁed proteins, which are ini-
tially essential in dealing with defects caused by the sgs1 mutation,
subsequently need to be removed from the damage site either by
ubiquitin-dependent degradation or by another process that requires
formation of longer SUMO chains. One possibility is that the segregase
Cdc48, maybe together with its co-factor Ufd1, both of which have
SUMO interacting properties [45,51,57,74–76], might act in removing
poly-sumoylated substrates from DNA damage sites. Consistent with
this notion, it was recently demonstrated that Cdc48–Ufd1–Npl4 are ca-
pable of preventing the accumulation of poly-sumoylated proteins in a
ﬁssion yeastmutant impaired in proteasome function [76]. The synthet-
ic growth defects of mutations affecting the Ufd1 SIM and Slx8 support
the conclusion that the Cdc48 segregase complex and ULS activity
depending on Slx8 operate in separate pathways to control poly-
sumoylated proteins. This is further supported by the observation that
this synthetic growth defect is suppressed by mutations in SUMO that
inhibit chain formation [76]. Together, these ﬁndings implicate Slx5–
Slx8 and its relative in ﬁssion yeast (discussed in more detail in a later
section) in the control of sumoylated proteins that accumulate at stalled
replication forks and DNA damage sites. Consistent with this notion,
Slx5 or Slx8 were shown to co-localize with DNA replication centers,
DNA double strand breaks, or Rad52 foci [77].
A recently reported genome-wide chromatin immunoprecipitation
(ChIP-chip) analysis revealed a stable centromer association of Slx5,
but not of Slx8 [78]. Additional experimentation prompted by these
ﬁndings showed that slx5 and slx8 mutants both displayed increased
chromosome missegregation leading to aneuploidy. This phenotype
could be related to defects in spindle positioning and dynamics [78].Fig. 2. Role of SUMO-ubiquitin hybrid conjugates in protein targeting. Depicted is a model illus
sumoylated proteins (ULSs or E3-S). A mono-sumoylated form of a substrate can either be des
chain is recognized bymultiple SUMO interactionmotifs (SIMs) of theULS enzyme, a RINGﬁnge
ubiquitin (Ub) moieties to the already SUMOmodiﬁed substrate. The ubiquitin modiﬁcationm
tive (upper part), a substrate carrying a hybrid SUMO-ubiquitin chain is recognized by a protei
actionmotifs (UIMs). Thismechanismwas shown tomediate recruitment of the Brca1-A compl
the activity of the ULS Rnf4. SIM color code corresponds to the one shown in Fig. 1.These ﬁndings, together with similar observations made upon knock-
down of RNF4 in human HeLa cells, indicated that these ULS enzymes
have a conserved function in maintaining genome integrity during mi-
tosis [78]. The authors of this study speculated that the increased DNA
damage observed in these ULS mutants may occur during mitosis as a
consequence of impaired chromosome segregation [78].
Slx5–Slx8, in addition, has been implicated in protein quality control
of nuclear proteins. A mutant version of transcriptional regulator Mot1
was found to be a SUMO-dependent substrate of Slx5–Slx8 [79]. Anoth-
er recent study carried out with human cells implicated the small heat
shock protein Hsp27 in a similar SUMO-dependent process. Hsp27 pro-
moted sumoylation of a mutant version of the cystic ﬁbrosis transmem-
brane conductance regulator (CFTR). The sumoylated forms of CFTR
were shown to be targeted for proteasomal degradation by the ULS
RNF4 [80]. These ﬁndings are consistent with the observation that
sumoylated forms of proteins accumulate under conditions that induce
protein misfolding [79,81].
Slx5–Slx8 appears to have also SUMO-independent functions as it
was shown to target the transcriptional repressorMatα2 independently
of whether the cellular sumoylation system was inhibited or not. Inter-
estingly, however, mutation of multiple SIMs in Slx5–Slx8, which
inhibited SUMObinding, also inhibited the activity of the ligase towards
Matα2 suggesting that this protein might expose surface features that
resemble the ones that SIMs recognize in SUMO [82]. In more general
terms, such SUMO-mimetic features of proteins could thus be consid-
ered as signals mediating ULS-dependent targeting.
3.1.3. S. cerevisiae Rad18
The sliding clamp protein proliferating cell nuclear antigen (PCNA)
is a cofactor of DNA polymerases that coordinates their recruitment
and functions during DNA replication as well as in damage repair [83].
PCNA interaction properties are regulated by competing modiﬁcationstrating targeting of sumoylated forms of a substrate mediated by ubiquitin ligases (E3) for
umoylated by an ULP/SENP enzyme or be polysumoylated. The substrate-attached SUMO
rprotein that, in conjunctionwith a ubiquitin-conjugating enzyme (E2) attaches additional
ay ﬁnally result in targeting of the substrate to the proteasome (lower part). As an alterna-
n such as Rap80 (a subunit of the Brca1 complex) bearing a SIM as well as ubiquitin inter-
ex to the sites of DNA damage, where such hybrid conjugates are generated as the result of
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observed during S phase andwas shown tomediate interactionwith the
Srs2 helicase, which inhibits untimely recombination by preventing for-
mation of Rad51 ﬁlaments [84,86–88]. More recently it was shown in S.
cerevisiae that particularly the sumoylated form of PCNA is a physiolog-
ical substrate of the RING ﬁnger ubiquitin ligase Rad18. Sumoylation of
PCNA enhances recognition and ubiquitylation by Rad18 in vitro but is
not essential for it. Binding of SUMO by Rad18 is mediated by a single
typical SIM (Fig. 1), which classiﬁes yeast Rad18 as an ULS-like enzyme
apparently with a speciﬁcity for a mono-sumoylated substrate [89]. It
was proposed that the preference of yeast Rad18 for sumoylated
PCNA may assure a direct transition of a PCNA trimer, in which at
least one subunit is sumoylated, to its ubiquitylated form, a mechanism
which could be particularly important when replication problems or
DNA damage occur [89]. The SUMO-enhanced ULS-like function of S.
cerevisiae Rad18, however, is not conserved, as the SIM is absent from
human Rad18. Accordingly, human Rad18 does not show an enhanced
activity towards sumoylated PCNA [89]. Nonetheless, this example
shows that the targeting efﬁciency of a substrate that is selected by a
SIM-independent binding site in an ULS can be modulated by an addi-
tional SUMO–SIM interaction. A similar but even more complex exam-
ple of such a recognition mode may be the one described in a later
section for the Drosophila ULS Degringolade.
3.1.4. S. pombe RFP1,2–SLX8
A ﬁssion yeast ULS composed of Slx8, an apparent ortholog of bud-
ding yeast Slx8, and one of two redundant RING ﬁnger proteinswith se-
quence similarity to human Rnf4, namely Rfp1 or Rfp2, has been
implicated in genome stability and DNA damage repair (Fig. 1)
[47,48,90]. Mutations impairing the function of this ULS led to an accu-
mulation of SUMO conjugates and a suppression of growth defects
caused by deletion of the SUMO ligase gene pli1 [47,91]. One relevant
substratewas recently shown to be topoisomerase I (Top1), sumoylated
forms of which accumulate in slx8mutants in a Pli1-dependentmanner
[91]. These observations indicated that Rfp1/2–Slx8 down-regulates
SUMO conjugates. Rfp1/2–Slx8 was shown to bind SUMO conjugates
via multiple SIMs. It was also shown to ubiquitylate either a GST-
SUMO fusion protein or the Rad60 protein in vitro [47,48]. The latter is
a conserved protein bearing two SUMO-like domains that has been im-
plicated in the DNA damage response.
Mutants affected in the function of Rfp1/2–Slx8 indicated that this
ULS has an important role in preventing the accumulation of DNA dam-
age as detected by the increased formation of Rad22 (S. pombe Rad52)
foci [47]. Additional data suggest that Rfp1,2–Slx8 is required to remove
proteins from repair sites that are sumoylated in response to DNA dam-
age or replication fork arrests [92]. One relevant mechanisms is the
Slx8-dependent suppression of DNA damage and genome instability
caused by unrepaired covalent Top1-DNA adducts (Top1-cc) [93]. Slx8
is required for a process of Top1-cc repair that is mediated by the
Rad16-Swi10 endonuclease. This process appears not to be mediated
by Pli1 but by the Nse2-based SUMO ligase, and is not clear whether
Top1 is the relevant Slx8 target in this context [93].
3.2. Human ULS enzymes
3.2.1. Rnf4
The human Rnf4 protein (also known as small nuclear RING ﬁn-
ger protein (SNURF) [94]) is probably the most extensively studied
ULS at this point in time [37,42,43,47,48]. Although with only 190
amino acid residues it is the smallest ULS characterized thus far,
Rnf4 comprises at least three clear SIMs (Fig. 1). These SIMs medi-
ate a similar binding to SUMO1 and SUMO2, with a preference for
chains of a length of at least 3 SUMO moieties [42]. These proper-
ties of the Rnf4 SIM domain enabled its utilization as a binding plat-
form for puriﬁcation and identiﬁcation of polysumoylated proteins
[21]. Rnf4 functions as a homodimer, in which the RING domains ofboth subunits make contact with a single ubiquitin-charged E2
[95–97].
The promyelocytic leukemia protein (PML) was identiﬁed as a ﬁrst
physiological substrate of Rnf4. The PML protein, aswell as its oncogenic
variant PML-RARα (a fusion protein with the retinoic acid receptor α
expressed as a result of a chromosomal translocation in patients with
acute promyelocytic leukemia), were earlier shown to be degraded in
a SUMO-dependentmanner by the proteasome after treatmentwith ar-
senic trioxide (ATO) [98].While no ubiquitylation prior to ATO-induced
degradation was observed in this study, the discovery of proteins with
ULS activity suggested a SUMO- and ubiquitin-dependent mechanism
[40]. Several studies proved this to be the case and revealed that Rnf4
is a ubiquitin ligase mediating ATO-induced proteolytic targeting of
PML. Rnf4 was shown to promote ubiquitylation of sumoylated PML
in vitro and to disrupt PML nuclear bodies (PML-NBs) in cells treated
with ATO [37,42,43]. The increase in PML sumoylation upon ATO treat-
ment can at least in part be explained by direct binding of ATO to PML,
which results in PML oligomerization and an increased afﬁnity for the
SUMO conjugating enzyme Ubc9 [99]. Rnf4-mediated ubiquitylation
then targets polysumoylated PML for degradation by the proteasome.
Ubiquitylation of sumoylated PML by Rnf4 was found to occur both on
lysine residues of SUMO and of PML. As ubiquitin–ubiquitin linkages in-
cluding K48 linked ones were detected among the hybrid conjugates,
sumoylated PML is apparently poly-ubiquitylated by Rnf4 [42,43]. The
latter modiﬁcation is sufﬁcient to explain the recognition by the
ubiquitin receptors present in the 26S proteasome [100]. Rnf4 was
shown to localize to PML-NBs in a SIM- and SUMO2/3-dependent man-
ner [42,101,102]. Because PML-NBs are a place where, aside from PML,
multiple sumoylated proteins such as Sp100 and Daxx come together
[103,104], it is a likely possibility that other PML-NB components are
targets of Rnf4 as well.
Another physiological Rnf4 substrate that was shown to be targeted
for proteasomal degradation is the kinetochore protein CENP-I. The ob-
servation that Senp6, a SUMO chain depolymerizing enzyme, inhibited
Rnf4-mediated degradation of CENP-I indicates that its targeting, simi-
lar to what was concluded for PML, involves SUMO chain formation.
Consistent with this notion, HMW-SUMO2/3-conjugates of CENP-I ac-
cumulated upon depletion of Rnf4 or upon inhibition of the proteasome
[105].
In addition, Rnf4 has been implicated in the proteolytic control of
sumoylated hypoxia-inducible factors (HIFs) [106]. Hif1α and Hif2α
are transcriptional activators with important roles in fetal development
and during tumor angiogenesis [107]. Oxygen deprivation (hypoxia)
leads to increased sumoylation of both activators. Depletion of Rnf4
was shown to cause an accumulation of SUMO2/3-modiﬁed forms of
Hif2α without apparent effects on the overall level of the protein. The
von Hippel–Lindau (VHL) ubiquitin ligase, which had earlier been im-
plicated in a proteolytic control of sumoylated Hif1α [108], apparently
also contributes to the accumulation of sumoylated Hif2α [106]. VHL
function itself is inhibited by PIASy-mediated sumoylation, which is in-
duced upon hypoxia [109]. At this point in time, a typical SIM or an al-
ternative SUMO binding site in VHL has not been mapped down to the
level of amino acid residues. It will be interesting to understand the
mechanistic details of how VHL acts on sumoylated HIFs.
Another transcription factor, the activity of which is controlled by
sumoylation and Rnf4-mediated ubiquitylation is Pea3. This
transcription factor is activated by extracellular signal-regulated ki-
nase (ERK) mitogen-activated protein (MAP) kinase signaling in a
SUMO-dependent manner [110]. Pea3 was shown to be
ubiquitylated by Rnf4 following its sumoylation and to be degraded
by the proteasome. Knockdown experiments indicated that Rnf4-
mediated ubiquitylation of Pea3 is required for full transcriptional
activation of its target genes. This could either be explained by a di-
rect role of the ubiquitin modiﬁcation in transcriptional activation
and/or a requirement of transcription factor recycling in a sustained
activation [110].
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scriptional response to heat shock by promoting SUMO-dependent
ubiquitylation and proteasomal degradation of poly(ADP-ribose)
polymerase 1 (PARP-1) [111]. This study revealed that PARP-1 func-
tion in heat-induced transcription of the Hsp70.1 gene is promoted
by its PIASy-mediated sumoylation. Rnf4-mediated ubiquitylation
of sumoylated PARP-1 was furthermore shown to be required for
full Hsp70.1 expression both under induced and non-induced condi-
tions, possibly by promoting rapid recycling of PARP-1 [111].
Rnf4 was reported to be essential for embryogenesis in mice and
identiﬁed as a factor promoting DNA demethylation [112]. In this
study, Rnf4 was shown to bind to the relevant enzymes thymine DNA
glycosylase (TDG) and apurinic/apyrimidinic (AP) site endonuclease
(APE1). TheRnf4 SIMdomainwas sufﬁcient for this interaction, butmu-
tation of all known SIMs did not prevent binding. These data suggested
that SUMO–SIM interactions and hence ULS activity may not be in-
volved in the regulation of TDG and APE1 by Rnf4. On the other hand,
there is evidence that TDG localizes to PML-NBs in a SUMO-dependent
manner [113], which would ﬁt well with a role of SUMO in Rnf4-
mediated regulation of TDG.
Another interesting target of Rnf4 is Human T-cell Leukemia Virus
Type 1 (HTLV-1) oncoprotein Tax. The localization of the Tax protein
in nuclear speckles is promoted by sumoylation. DNA damage-induced
translocation of Tax from the nucleus to the cytosol requires Rnf4
[114]. This study indicated that Rnf4-mediated ubiquitylation does not
always mediate proteasomal degradation of its substrate but can also
have an inﬂuence on its subcellular localization. Consistent with this as-
sumption, it was shown recently that Rnf4, when operating together
with the E2 Ube2w in vitro, is capable of attaching a single ubiquitin to
the amino terminus of a SUMO chain [115]. Together with another E2,
Ubc13–Uev1, Rnf4 can use N-terminally mono-ubiquitylated SUMO
chains as a substrate to add K63-linked ubiquitin chains. Such chains
are not expected to mediate degradation by the proteasome, but have
been observed to accumulate at DNA damage sites as a result of Rnf4 ac-
tivity [116,117].
Rnf4 has also been shown to target a mutant version of CFTR impli-
cating this ULS in protein quality control, similar to what has been sug-
gested for Slx5–Slx8 in budding yeast (see above) [118].
Despite the large differences in sequence, size and overall structure,
Rnf4 was shown to suppress phenotypes of mutants impaired in Slx5–
Slx8 function in S. cerevisiae or in Rfp1,2–Slx8 function in S. pombe,
which are related to functions of these ULSs in DNA damage repair
and processing of stalled replication forks [40,47,48]. Because these
ubiquitin ligases do not have much in common beyond their RING do-
mains and the presence of SIMs, these observations suggested that
ubiquitylation of sumoylated proteins (bona ﬁde ULS activity) is under-
lying the observed suppression and is thus an evolutionary conserved
biochemical process with important cellular functions. These ﬁndings
point to important roles of ULS activity in the response to DNA damage
and replication problems, which are discussed in more detail further
down in a separate section focusing on this subject.
3.2.2. Arkadia/RNF111
A recent study that used a bioinformatic approach to search for
human proteins with multiple SIMs identiﬁed the RING ﬁnger protein
Arkadia (also known as RNF111) as a novel ULS (Fig. 1) [119]. Arkadia
is a ubiquitin ligase that promotes TGF-β (transforming growth factor
β) signaling by targeting negative regulators such as SMAD7, c-Ski or
SnoN for degradation [120]. In this signaling pathway, binding of TGF-
β to its receptor results in phosphorylation of Smad3 and its release
from Axin. Smad3 then joins with Smad4 to enter into the nucleus and
activate transcription of target genes. This process is negatively regulat-
ed by SMAD7, which binds to Axin and prevents release of Smad3.
Arkadia has been shown to mediate ubiquitylation and degradation of
Smad7 as well as of other negative regulators of TGF-β signaling such
as c-Ski or SnoN [120]. Interestingly, several players in the c-Ski TGF-βsignaling pathway, namely TGF-β receptor, Smad3, Smad4 and Axin
were reported to be modiﬁed by sumoylation [121–125]. It is therefore
an intriguing possibility that Arkadia activity in the TGF-β pathway in-
volves its function as an ULS [119]. Arkadia bears at least 3 functional
SIMs, which are closely spaced, analogously to the situation for RNF4
(Fig. 1). These SIMs are similar to a VIDLT consensus sequence (classiﬁed
as type-b in [5]) andwere shown tomediate particularly strong binding
of artiﬁcial linear SUMO1 or SUMO2 chains suggesting that the function
of Arkadia involves the recognition of poly-SUMO signals [119]. Another
study identiﬁed the promyelocytic leukemia (PML) protein as one
in vivo substrate of Arkadia [126]. It was shown that depletion of
Arkadia caused an accumulation of poly-sumoylated PML upon treat-
ment with ATO. This effect was synergistic with that of Rnf4 depletion.
Based upon this observation, it was suggested that Rnf4 and Arkadia,
which form homo-dimers but no heterodimers with each other, both
contribute to ATO-induced and SUMO-dependent degradation of PML
[126]. While SIMs of Arkadia appear to be required for its function in
targeting PML, the authors of this study came to the conclusion that
they are not essential for SnoN/Ski degradation in response to TGFβ
[126]. Sun and colleagues, in contrast, promote the view that SUMO
binding by Arkadia, and its RING domain-mediated ubiquitin ligase ac-
tivity together, i.e. its ULS activity, have a speciﬁc role in the TGFβ path-
way [119].
3.3. Drosophila Degringolade
Degringolade (Dgrn) (Fig. 1), a protein related to RNF4, has been
identiﬁed in Drosophila as a negative regulator of the developmental
transcription factor Hairy, which has an important role during embry-
onic segmentation and neurogenesis, and of its co-repressor Groucho
[127–129]. Dgrn mutations suppress the embryonic lethality of hairy
mutants. Targeting of Hairy present in a complex with Groucho by
Dgrn involves an intriguing recognition mechanism. Via its RING do-
main, Dgrn binds to a basic region of Hairy. Simultaneously, it binds to
sumoylated Groucho via its SIMs [128,130]. As a consequence, Hairy is
ubiquitylated and separated from Groucho. Ubiquitylation of Groucho
itself was not detected [128]. Thismechanism thus appears to represent
an example, in which the SUMO–SIM interaction cooperates with an-
other binding site to provide speciﬁc recognition of a substrate by an
ULS.
3.4. Viral ULS enzymes
The cellular SUMO protein modiﬁcation system is functionally
intertwined with the biology of viruses in multiple ways (see [131] for
a recent review). Several viruses express RING ﬁnger ubiquitin ligases
bearing SIMs that have recently been shown to possess ULS activity
(Fig. 1) [132,133].
3.4.1. ICP0
The ‘Infected Cell Polypeptide 0’ (ICP0) RING ﬁnger ubiquitin ligase
of herpes simplex virus 1 (HSV-1) is important for efﬁcient initiation
of lytic infection aswell as for reactivation of viral genomes from latency
[132]. It was shown that, upon infection with ICP0-null mutant viruses,
proteins stored in PML nuclear bodies (NBs) such as PML, Sp100, hDaxx
and ATRX accumulate on the viral DNA and prevent its replication. This
recruitment of host proteins to the viral DNA is dependent on SUMO–
SIM-mediated interaction [134]. Upon infection, SUMO1 and SUMO2/3
conjugates are enriched at sites of viral genomes [135]. This response
is a part of the intrinsic antiviral defense mechanism, and the virus
uses ICP0 as a counteractive measure [132]. Consistent with a role of
ICP0 as an ULS, HSV-1 infection promotes a general loss of HMW-
SUMO conjugates in a proteasome-dependent manner. ICP0 also pro-
motes disruption of PML-NBs and the degradation of PML [136]. ICP0 re-
quires its C-terminal domain for binding to the deubiquitylating
enzyme Usp7/HAUSP, and PML-NB localization sequences to efﬁciently
81A.M. Sriramachandran, R.J. Dohmen / Biochimica et Biophysica Acta 1843 (2014) 75–85target SUMO conjugates for proteasomal degradation [135]. Upon infec-
tion with ICP0-null mutant virus, there is an accumulation of SUMO1
and SUMO2/3 conjugates.
ICP0 has at least 3 SIMs that were shown to be important for the
down-regulation of cellular SUMO conjugates as well as of PML
(Fig. 1) [135]. The SIMs in ICP0 appear to function cooperatively and
to some degree redundantly as is suggested by the observation that a
triplemutant shows amore drastic effect on SUMO conjugates than sin-
gle or double mutants [135]. ICP0 targets PML more efﬁciently than
SUMO conjugates in general. However, whereas PML isoforms II–VI re-
quired sumoylation to be recognized by ICP0, only isoform I is also
targeted without sumoylation. Together these data suggest a dual
targeting mechanism for ICP0, in which both intrinsic signals in its sub-
strate (PML) as well as the SUMO modiﬁcation on it can be recognized
by the ligase [135]. In line with a contribution of SUMO-independent
recognition, ICP0 is also thought to target proteins such as RNF8, p53
and USP7 in a SUMO-independent manner [137–140].
3.4.2. ORF61p
ORF61p is a Varicella Zoster Virus ortholog of ICP0. Like ICP0, it is im-
portant for infectivity of the viral DNA. Both proteins target PML-NBs,
however ICP0 promotes ubiquitylation of both PML and Sp100, whereas
ORF61p speciﬁcally targets Sp100 [141,142]. Nonetheless, ORF61p pro-
motes dispersal of PML-NBs and can partially complement ICP0 null
mutations [142,143]. ORF61p has a much stronger afﬁnity for SUMO1
than for SUMO2/3. It has three SIMs, two closely spaced near the RING
domain, and a third one closer to its C-terminus (Fig. 1). The C-
terminal type-b SIM appears to provide the main binding afﬁnity for
SUMO whereas the other two appear to have only supporting roles.
These SIMs are required for the association with and dispersion of
PML-NBs, whereas the RING domain is not required for the association
with PML-NBs but for their dispersal. The SIMs are also of critical impor-
tance for normal viral replication and for the typical VSV-mediated le-
sions to occur [143].
Similar to ICP0, ORF61p also appears to target substrates for
proteasomal degradation in a SUMO-independentmanner. Suppression
of NF-κB activation by TNF-α, for example, requires a functional RING
domain of ORF61p but not its SIMs [143]. These data indicate that
ORF61p uses substrate binding sites other than the SIMs to recognize
some of its substrates.
4. ULS enzymes in genome stability and DNA damage repair
The analysis of yeast mutants deﬁcient either in SUMO conjugation
or in chain depolymerization revealed that the SUMO system has im-
portant roles in the resistance to various forms of DNA damage
[39,84,85,144–149]. An intact SUMO pathway appears to be important
for the recovery from DNA damage checkpoint-induced arrest [51].
Many additional studies not only with yeast but also with mammalian
cells implicated SUMO modiﬁcation in the control of genome stability
(for more details on the role of SUMO in the regulation DNA damage re-
pair and chromatin function, see recent reviews [6,92,150–153]). Sys-
tematic studies identiﬁed many proteins involved either in double
strand break (DSB) repair or in nucleotide excision repair (NER) that
are SUMO modiﬁed, and their modiﬁcation is enhanced in response to
DNA damage [38,56,154]. Such ﬁndings led to the conclusion that a si-
multaneous sumoylation of many DNA damage repair factors results
in a synergistic stimulation of repair processes probably by stabilizing
physical interactions of these proteins [56].
Assessment of the SUMO2 conjugated forms of proteins that increase
upon proteasome inhibition revealed that many DNA repair factors are
among these proteins [155]. This observation indicated that ULS-
mediated proteolytic targeting may play an important role in the recov-
ery from DNA damage and the concomitant induction of sumoylation of
many proteins. Indeed, multiple lines of evidence have implicated ULSs
in DNA damage responses. As mentioned in earlier sections devoted tothese speciﬁc ULSs, budding yeast Uls1 and Uls2/Slx5–Slx8 were shown
to display opposite genetic interactions with mutations affecting the
Sgs1 DNA helicase. While slx5 or slx8mutations show synthetic lethality
with sgs1 mutations, they were suppressed by the inactivation of ULS1.
Similar to mutations affecting the Rfp1,2–Slx8 protein in S. pombe, slx5
and slx8mutations cause accumulation of DNA damage [77,92].
Studies with human cells have implicated SUMO protein modiﬁca-
tion, together with ubiquitylation, in the assembly and disassembly of
repair factors at DNA double strand breaks (DSB) by contributing to
the recruitment of several important factors such as Brca1 and Rnf168
that are required for ubiquitin modiﬁcations at these sites (see refer-
ence [153] for a recent review). Recent work has revealed an important
function of Rnf4 in DSB repair [117,156–158]. Rnf4 is recruited to DSB
sites by sumoylated proteins such as 53BP1, Mdc1, and RPA. Depletion
of Rnf4 caused DNA damage hypersensitivity and defects in the loading
of RPA1, Rad51 and CtIP onto single-stranded DNA. As a consequence,
Rnf4-depleted cells were impaired in homologous recombination. In
one study, a decrease mainly of K63-linkeage-dependent poly-
ubiquitylation was observed at DNA damage sites upon Rnf4 depletion
[117]. Formation of K63 chains would favor a non-proteolytic role of
Rnf4 activity in this process [116]. The other two studies, however,
suggested, based in part upon experiments involving proteasome inhi-
bition and the effects of a ubiquitin mutant (K48R) preventing forma-
tion of K48-linked ubiquitin chains, that Rnf4-mediated ubiquitylation
of Mdc1 leads to its proteolytic targeting [156,157]. Support for the no-
tion that at least some of the Rnf4-mediated ubiquitylation at DSB sites
promotes removal and degradation of repair factors comes from the
observation that proteasomes were recruited to damage sites in an
Rnf4-dependent manner and that inhibition of the proteasome had
similar effects on the events at DSB sites as Rnf4 depletion [156]. The
p97/Cdc48 segregase together with its co-factor Ufd1, which were
recently shown not only to act on ubiquitylated substrates but also to
recognize SUMO-modiﬁed proteins, may have a role in the extraction
of products of Rnf4 activity fromDNAdamage sites [153,159]. The avail-
able data indicate that the functions of Rnf4 at DNA damage sites are
likely to involve both proteolytic and non-proteolytic ones. The impor-
tance of non-proteolytic functions of Rnf4 at DNA-damage sites can be
derived from the observation that it promotes Brca1-1 recruitment by
generating SUMO-ubiquitin hybrid conjugates recognized by Rap80,
as discussed in more detail in the following section.
5. SUMO-ubiquitin hybrid chains as a composite recognition signal
One result of ULS activity occurring upon DNA damage is the gener-
ation of thus far unidentiﬁed proteins that are modiﬁed with both
SUMO and ubiquitin. Apart from generating versions of sumoylated
proteins, which are recognized at the level of the proteasome by their
poly-ubiquitin tags, ULS-mediated attachment of ubiquitin or ubiquitin
chains to SUMO or SUMO chains also creates hybrid chains that provide
a novel composite recognition signal (Fig. 2). The relevance of the latter
became apparent through the analysis of the properties of Rap80, a
subunit of the Brca1-1 ubiquitin ligase complex. Rap80 was shown to
carry two ubiquitin interaction motifs (UIMs) and one SIM [160,161].
The combination of these motifs provides a selective recognition of hy-
brid SUMO-ubiquitin chains [160]. These properties of Rap80 are impor-
tant to direct the Brca1-1 complex to DNA damage sites [160,161]. The
identity of a relevant Rnf4 substrate that attracts Rap80 has not yet
been revealed, but among the candidates are sumoylated histones,
MDC1 as well as other repair factors [160].
Based upon the above-mentioned ﬁndings, it was proposed that
more proteins exist that, by combining ubiquitin and SUMO binding
motifs, are equipped to speciﬁcally decode hybrid chain signals generat-
ed byULS activity [162]. One of theproteins thatwas considered as a pu-
tative hybrid chain receptor is S5a/Rpn10, which is known to serve as a
ubiquitin receptor of the proteasome. Rpn10 bears a UIM and a putative
SIM [162]. This entails the possibility that Rpn10 might promote
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other SIM-containing and therefore SUMO binding protein that was
shown to interact with the proteasome is the Wss1 protein. Wss1 was
reported not only to deconjugate ubiquitin from SUMO chains in vitro
but also to depolymerize SUMO chains. Genetic data indicate that
Wss1 is important for degradation of poly-sumoylated proteins by the
proteasome in vivo [163]. Together, these ﬁndings indicate that speciﬁc
functions may be necessary for recognition and processing of SUMO-
ubiquitin hybrid conjugates at the proteasome. Of relevance in this con-
text may be also the recent observation that the Cdc48 segregase, to-
gether with its co-factor Ufd1, which was known to promote the
ubiquitin-dependent degradation of proteins [164,165], also mediates
the processing of sumoylated proteins [57,76]. Whether Cdc48 is also
involved in proteasomal targeting of sumoylated proteins, however, is
presently unknown. There is clearly more to be learned about the iden-
tities and exact roles of factors involved in proteasomal processing of
sumoylated proteins.
6. SUMO chains as ubiquitin-dependent proteolytic targeting signals
The observation that HMW-SUMO conjugates, the formation of
which depends on Lys residues required for efﬁcient chain formation,
accumulate in cells lacking ULSs or with impaired proteasome function
suggested that proteolytic targeting of poly-sumoylated substrates is
one important ULS function [40]. This concept received strong support
from the characterization of the human Rnf4 ULS and its substrates
PML, CENP1, Hif2α, Pea3, PARP-1, and Mdc1, all of which appear to be
targeted for degradation in a SUMO2/3- and Rnf4-dependent manner
(see Section Rnf4). Mass spectrometric analyses revealed that multiple
Lys (K) residues in SUMO are ubiquitylated in cells. The majority
(N50%) of ubiquitin linkages of SUMO2/3 involve its K11 residue,
which is also the sumoylation consensus site that promotes SUMO2/3
chain formation [166]. This observation suggests that ubiquitin modiﬁ-
cation of SUMO2/3 oftenmay result in a termination of SUMO chain ex-
tension. SUMO conjugation and chain formation is strongly increased
upon cellular stress and DNA damage. Based upon the example of
DNA damage response, it was suggested that SUMO modiﬁcation may
simultaneously target multiple or many proteins of a functional group
to coordinate a response by promoting interaction and assembly of rel-
evant factors [56]. It is a likely scenario that such waves of sumoylation
require a successional wave of desumoylation and ULS-mediated prote-
olysis to return to the resting state. Another stress-related function of
SUMO chains could be a role in quality control [38,79,81]. Poly-
sumoylation could on one hand promote aggregation of abnormal pro-
teins and on the other hand mediate their ULS-dependent proteolysis.
7. Concluding remarks
The recently discovered class of ULS enzymes provides a strong link
between the SUMO proteinmodiﬁcation system and the UPS. One func-
tion of a combination of SUMO and ubiquitin modiﬁcations is to gener-
ate a new modular recognition motif that has recently been implicated
in the coordination of DNA damage responses. The composite SUMO-
ubiquitin tag is recognized by proteins, such as RAP80, which bear
both SUMO and ubiquitin interaction motifs. Another important aspect
of the ubiquitylation of sumoylated proteins is to mediate their proteo-
lytic control by targeting them for degradation by the 26S proteasome.
This provides a mechanism, in addition to, but in its result also distinct
from desumoylation that contributes to the transient nature of SUMO
proteinmodiﬁcation. Thismechanism is also employed by certain virus-
es to counteract SUMO-dependent anti-viral responses. Research on
ULS enzymes is still in an early phase with additional such enzymes
bearing distinct speciﬁcities, substrates and functions still to be discov-
ered. It will be also interesting to see whether analogous enzymes exist
that speciﬁcally recognize and target substrates conjugated to other
ubiquitin family modiﬁer such as Nedd8, ISG15 or FAT10.Acknowledgements
This work is supported by a grant from the Deutsche
Forschungsgemeinschaft (Do 649/5) within in the program SPP1365.References
[1] E.S. Johnson, I. Schwienhorst, R.J. Dohmen, G. Blobel, The ubiquitin-like protein
Smt3p is activated for conjugation to other proteins by anAos1p/Uba2pheterodimer,
EMBO J. 16 (1997) 5509–5519.
[2] K. Nacerddine, F. Lehembre, M. Bhaumik, J. Artus, M. Cohen-Tannoudji, C. Babinet,
P.P. Pandolﬁ, A. Dejean, The SUMO pathway is essential for nuclear integrity and
chromosome segregation in mice, Dev. Cell 9 (2005) 769–779.
[3] K. Tanaka, J. Nishide, K. Okazaki, H. Kato, O. Niwa, T. Nakagawa, H. Matsuda, M.
Kawamukai, Y. Murakami, Characterization of a ﬁssion yeast SUMO-1 homologue,
pmt3p, required for multiple nuclear events, including the control of telomere
length and chromosome segregation, Mol. Cell. Biol. 19 (1999) 8660–8672.
[4] M. Novatchkova, K. Tomanov, K. Hofmann, H.P. Stuible, A. Bachmair, Update on
sumoylation: deﬁning core components of the plant SUMO conjugation system
by phylogenetic comparison, New Phytol. 195 (2012) 23–31.
[5] M. Miteva, K. Keusekotten, K. Hofmann, G.J. Praefcke, R.J. Dohmen, Sumoylation as
a signal for polyubiquitylation and proteasomal degradation, Subcell. Biochem. 54
(2010) 195–214.
[6] C. Cubenas-Potts, M.J. Matunis, SUMO: a multifaceted modiﬁer of chromatin struc-
ture and function, Dev. Cell 24 (2013) 1–12.
[7] N. Livnat-Levanon, M.H. Glickman, Ubiquitin–proteasome system and mitochon-
dria — reciprocity, Biochim. Biophys. Acta 1809 (2011) 80–87.
[8] H.D. Ulrich, Mutual interactions between the SUMO and ubiquitin systems: a plea
of no contest, Trends Cell Biol. 15 (2005) 525–532.
[9] G.J. Praefcke, K. Hofmann, R.J. Dohmen, SUMO playing tag with ubiquitin, Trends
Biochem. Sci. 37 (2012) 23–31.
[10] E.S. Johnson, Protein modiﬁcation by SUMO, Annu. Rev. Biochem. 73 (2004)
355–382.
[11] M.H. Tatham, E. Jaffray, O.A. Vaughan, J.M. Desterro, C.H. Botting, J.H. Naismith, R.T.
Hay, Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein sub-
strates by SAE1/SAE2 and Ubc9, J. Biol. Chem. 276 (2001) 35368–35374.
[12] G.R. Bylebyl, I. Belichenko, E.S. Johnson, The SUMO isopeptidase Ulp2 prevents ac-
cumulation of SUMO chains in yeast, J. Biol. Chem. 278 (2003) 44113–44120.
[13] A. Pichler, A. Gast, J.S. Seeler, A. Dejean, F. Melchior, The nucleoporin RanBP2 has
SUMO1 E3 ligase activity, Cell 108 (2002) 109–120.
[14] M. Yang, C.T. Hsu, C.Y. Ting, L.F. Liu, J. Hwang, Assembly of a polymeric chain of
SUMO1 on human topoisomerase I in vitro, J. Biol. Chem. 281 (2006) 8264–8274.
[15] P.G. Pedrioli, B. Raught, X.D. Zhang, R. Rogers, J. Aitchison, M. Matunis, R. Aebersold,
Automated identiﬁcation of SUMOylation sites using mass spectrometry and SUM-
mOn pattern recognition software, Nat. Methods 3 (2006) 533–539.
[16] I. Matic, M. van Hagen, J. Schimmel, B. Macek, S.C. Ogg, M.H. Tatham, R.T. Hay, A.I.
Lamond, M. Mann, A.C. Vertegaal, In vivo identiﬁcation of human small
ubiquitin-like modiﬁer polymerization sites by high accuracy mass spectrometry
and an in vitro to in vivo strategy, Mol. Cell Proteomics 7 (2008) 132–144.
[17] S.M. Jeram, T. Srikumar, X.D. Zhang, H. Anne Eisenhauer, R. Rogers, P.G. Pedrioli, M.
Matunis, B. Raught, An improved SUMmOn-based methodology for the identiﬁca-
tion of ubiquitin and ubiquitin-like protein conjugation sites identiﬁes novel
ubiquitin-like protein chain linkages, Proteomics 10 (2010) 254–265.
[18] H.H. Hsiao, E. Meulmeester, B.T. Frank, F. Melchior, H. Urlaub, “ChopNSpice,” a
mass spectrometric approach that allows identiﬁcation of endogenous small
ubiquitin-like modiﬁer-conjugated peptides, Mol. Cell Proteomics 8 (2009)
2664–2675.
[19] H.A. Blomster, S.Y. Imanishi, J. Siimes, J. Kastu, N.A. Morrice, J.E. Eriksson, L.
Sistonen, In vivo identiﬁcation of sumoylation sites by a signature tag and
cysteine-targeted afﬁnity puriﬁcation, J. Biol. Chem. 285 (2010) 19324–19329.
[20] I. Matic, J. Schimmel, I.A. Hendriks, M.A. van Santen, F. van de Rijke, H. van Dam, F.
Gnad,M.Mann, A.C. Vertegaal, Site-speciﬁc identiﬁcation of SUMO-2 targets in cells
reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation
motif, Mol. Cell 39 (2010) 641–652.
[21] R. Bruderer, M.H. Tatham, A. Plechanovova, I. Matic, A.K. Garg, R.T. Hay, Puriﬁcation
and identiﬁcation of endogenous polySUMO conjugates, EMBO Rep. 12 (2011)
142–148.
[22] F. Galisson, L. Mahrouche, M. Courcelles, E. Bonneil, S. Meloche, M.K.
Chelbi-Alix, P. Thibault, A novel proteomics approach to identify SUMOylated
proteins and their modiﬁcation sites in human cells, Mol. Cell Proteomics 10
(2011)(M110 004796).
[23] D. Guo, M. Li, Y. Zhang, P. Yang, S. Eckenrode, D. Hopkins, W. Zheng, S. Purohit, R.H.
Podolsky, A. Muir, J. Wang, Z. Dong, T. Brusko, M. Atkinson, P. Pozzilli, A. Zeidler, L.J.
Raffel, C.O. Jacob, Y. Park, M. Serrano-Rios, M.T. Larrad, Z. Zhang, H.J. Garchon, J.F.
Bach, J.I. Rotter, J.X. She, C.Y. Wang, A functional variant of SUMO4, a new I
kappa B alpha modiﬁer, is associated with type 1 diabetes, Nat. Genet. 36 (2004)
837–841.
[24] D. Owerbach, E.M. McKay, E.T. Yeh, K.H. Gabbay, K.M. Bohren, A proline-90 residue
unique to SUMO-4 prevents maturation and sumoylation, Biochem. Biophys. Res.
Commun. 337 (2005) 517–520.
[25] W.Wei, P. Yang, J. Pang, S. Zhang, Y. Wang,M.H.Wang, Z. Dong, J.X. She, C.Y. Wang,
A stress-dependent SUMO4 sumoylation of its substrate proteins, Biochem.
Biophys. Res. Commun. 375 (2008) 454–459.
83A.M. Sriramachandran, R.J. Dohmen / Biochimica et Biophysica Acta 1843 (2014) 75–85[26] S.J. Li, M. Hochstrasser, A new protease required for cell-cycle progression in yeast,
Nature 398 (1999) 246–251.
[27] L. Gong, S. Millas, G.G. Maul, E.T. Yeh, Differential regulation of sentrinized proteins
by a novel sentrin-speciﬁc protease, J. Biol. Chem. 275 (2000) 3355–3359.
[28] D. Mukhopadhyay, M. Dasso, Modiﬁcation in reverse: the SUMO proteases, Trends
Biochem. Sci. 32 (2007) 286–295.
[29] R.T. Hay, SUMO-speciﬁc proteases: a twist in the tail, Trends Cell Biol. 17 (2007)
370–376.
[30] E.T. Yeh, SUMOylation and De-SUMOylation: wrestling with life's processes, J. Biol.
Chem. 284 (2009) 8223–8227.
[31] C.M. Hickey, N.R. Wilson, M. Hochstrasser, Function and regulation of SUMO prote-
ases, Nat. Rev. Mol. Cell Biol. 13 (2012) 755–766.
[32] D.Mukhopadhyay, F. Ayaydin,N. Kolli, S.H. Tan, T. Anan, A. Kametaka, Y. Azuma, K.D.
Wilkinson, M. Dasso, SUSP1 antagonizes formation of highly SUMO2/3-conjugated
species, J. Cell Biol. 174 (2006) 939–949.
[33] L.N. Shen, M.C. Geoffroy, E.G. Jaffray, R.T. Hay, Characterization of SENP7, a
SUMO-2/3-speciﬁc isopeptidase, Biochem. J. 421 (2009) 223–230.
[34] H. Saitoh, J. Hinchey, Functional heterogeneity of small ubiquitin-related protein
modiﬁers SUMO-1 versus SUMO-2/3, J. Biol. Chem. 275 (2000) 6252–6258.
[35] W. Zhou, J.J. Ryan,H. Zhou, Global analyses of sumoylatedproteins in Saccharomyces
cerevisiae. Induction of protein sumoylation by cellular stresses, J. Biol. Chem. 279
(2004) 32262–32268.
[36] A. Skilton, J.C. Ho, B. Mercer, E. Outwin, F.Z. Watts, SUMO chain formation is re-
quired for response to replication arrest in S. pombe, PLoS One 4 (2009) e6750.
[37] S.R. Weisshaar, K. Keusekotten, A. Krause, C. Horst, H.M. Springer, K. Gottsche, R.J.
Dohmen, G.J. Praefcke, Arsenic trioxide stimulates SUMO-2/3 modiﬁcation leading
to RNF4-dependent proteolytic targeting of PML, FEBS Lett. 582 (2008)
3174–3178.
[38] F. Golebiowski, I. Matic, M.H. Tatham, C. Cole, Y. Yin, A. Nakamura, J. Cox, G.J.
Barton, M. Mann, R.T. Hay, System-wide changes to SUMO modiﬁcations in re-
sponse to heat shock, Sci. Signal. 2 (2009) ra24.
[39] T. Srikumar,M.C. Lewicki,M. Costanzo, J.M. Tkach,H. van Bakel, K. Tsui, E.S. Johnson,
G.W. Brown, B.J. Andrews, C. Boone, G. Giaever, C. Nislow, B. Raught, Global analysis
of SUMO chain function reveals multiple roles in chromatin regulation, J. Cell Biol.
201 (2013) 145–163.
[40] K. Uzunova, K. Göttsche, M. Miteva, S.R. Weisshaar, C. Glanemann, M. Schnellhardt,
M. Niessen, H. Scheel, K. Hofmann, E.S. Johnson, G.J. Praefcke, R.J. Dohmen,
Ubiquitin-dependent proteolytic control of SUMO conjugates, J. Biol. Chem. 282
(2007) 34167–34175.
[41] J.J. Perry, J.A. Tainer, M.N. Boddy, A SIM-ultaneous role for SUMO and ubiquitin,
Trends Biochem. Sci. 33 (2008) 201–208.
[42] M.H. Tatham, M.C. Geoffroy, L. Shen, A. Plechanovova, N. Hattersley, E.G. Jaffray, J.J.
Palvimo, R.T. Hay, RNF4 is a poly-SUMO-speciﬁc E3 ubiquitin ligase required for
arsenic-induced PML degradation, Nat. Cell Biol. 10 (2008) 538–546.
[43] V. Lallemand-Breitenbach, M. Jeanne, S. Benhenda, R. Nasr, M. Lei, L. Peres, J. Zhou,
J. Zhu, B. Raught, H. de The, Arsenic degrades PML or PML-RARalpha through a
SUMO-triggered RNF4/ubiquitin-mediated pathway, Nat. Cell Biol. 10 (2008)
547–555.
[44] I. Matic, R.T. Hay, Detection and quantitation of SUMO chains by mass spectrome-
try, Methods Mol. Biol. 832 (2012) 239–247.
[45] J.T. Hannich, A. Lewis, M.B. Kroetz, S.J. Li, H. Heide, A. Emili, M. Hochstrasser, Deﬁn-
ing the SUMO-modiﬁed proteome by multiple approaches in Saccharomyces
cerevisiae, J. Biol. Chem. 280 (2005) 4102–4110.
[46] Y. Xie, O. Kerscher, M.B. Kroetz, H.F. McConchie, P. Sung, M. Hochstrasser, The
yeast Hex3.Slx8 heterodimer is a ubiquitin ligase stimulated by substrate
sumoylation, J. Biol. Chem. 282 (2007) 34176–34184.
[47] J. Prudden, S. Pebernard, G. Raffa, D.A. Slavin, J.J. Perry, J.A. Tainer, C.H. McGowan,
M.N. Boddy, SUMO-targeted ubiquitin ligases in genome stability, EMBO J. 26
(2007) 4089–4101.
[48] H. Sun, J.D. Leverson, T. Hunter, Conserved function of RNF4 family proteins in eu-
karyotes: targeting a ubiquitin ligase to SUMOylated proteins, EMBO J. 26 (2007)
4102–4112.
[49] Z. Zhang, A.R. Buchman, Identiﬁcation of a member of a DNA-dependent
ATPase family that causes interference with silencing, Mol. Cell. Biol. 17
(1997) 5461–5472.
[50] M.E. Dresser, D.J. Ewing, M.N. Conrad, A.M. Dominguez, R. Barstead, H. Jiang, T.
Kodadek, DMC1 functions in a Saccharomyces cerevisiae meiotic pathway that is
largely independent of the RAD51 pathway, Genetics 147 (1997) 533–544.
[51] T. Makhnevych, Y. Sydorskyy, X. Xin, T. Srikumar, F.J. Vizeacoumar, S.M. Jeram,
Z. Li, S. Bahr, B.J. Andrews, C. Boone, B. Raught, Global map of SUMO function
revealed by protein–protein interaction and genetic networks, Mol. Cell 33
(2009) 124–135.
[52] P. Chi, Y. Kwon, M.L. Visnapuu, I. Lam, S.R. Santa Maria, X. Zheng, A. Epshtein, E.C.
Greene, P. Sung, H.L. Klein, Analyses of the yeast Rad51 recombinase A265V mu-
tant reveal different in vivo roles of Swi2-like factors, Nucleic Acids Res. 39
(2011) 6511–6522.
[53] P.P. Shah, X. Zheng, A. Epshtein, J.N. Carey, D.K. Bishop,H.L. Klein, Swi2/Snf2-related
translocases prevent accumulation of toxic Rad51 complexes during mitotic
growth, Mol. Cell 39 (2010) 862–872.
[54] J.A. Cobb, L. Bjergbaek, RecQ helicases: lessons from model organisms, Nucleic
Acids Res. 34 (2006) 4106–4114.
[55] M. Cal-Bakowska, I. Litwin, T. Bocer, R. Wysocki, D. Dziadkowiec, The Swi2–
Snf2-like protein Uls1 is involved in replication stress response, Nucleic Acids
Res. 39 (2011) 8765–8777.
[56] I. Psakhye, S. Jentsch, Protein group modiﬁcation and synergy in the SUMO path-
way as exempliﬁed in DNA repair, Cell 151 (2012) 807–820.[57] S. Bergink, T. Ammon, M. Kern, L. Schermelleh, H. Leonhardt, S. Jentsch, Role of
Cdc48/p97 as a SUMO-targeted segregase curbing Rad51–Rad52 interaction, Nat.
Cell Biol. 15 (2013) 526–532.
[58] C.H. Cheng, Y.H. Lo, S.S. Liang, S.C. Ti, F.M. Lin, C.H. Yeh, H.Y. Huang, T.F. Wang,
SUMOmodiﬁcations control assembly of synaptonemal complex and polycomplex
in meiosis of Saccharomyces cerevisiae, Genes Dev. 20 (2006) 2067–2081.
[59] C.E. de Carvalho, M.P. Colaiacovo, SUMO-mediated regulation of synaptonemal
complex formation during meiosis, Genes Dev. 20 (2006) 1986–1992.
[60] H. Klug, M. Xaver, V.K. Chaugule, S. Koidl, G. Mittler, F. Klein, A. Pichler, Ubc9
sumoylation controls SUMO chain formation andmeiotic synapsis in Saccharomyces
cerevisiae, Mol. Cell 50 (2013) 625–636.
[61] R. Lescasse, S. Pobiega, I. Callebaut, S. Marcand, End-joining inhibition at telomeres
requires the translocase and polySUMO-dependent ubiquitin ligase Uls1, EMBO J.
32 (2013) 805–815.
[62] C. Shirai, K. Mizuta, SUMO mediates interaction of Ebp2p, the yeast homolog of
Epstein–Barr virus nuclear antigen 1-binding protein 2, with a RING ﬁnger protein
Ris1p, Biosci. Biotechnol. Biochem. 72 (2008) 1881–1886.
[63] W. Tan, Z. Wang, G. Prelich, Physical and Genetic Interactions between Uls1 and
the Slx5–Slx8 SUMO-Targeted Ubiquitin Ligase, G3 (Bethesda), 2013.
[64] L. Yang, J.R. Mullen, S.J. Brill, Puriﬁcation of the yeast Slx5–Slx8 protein complex
and characterization of its DNA-binding activity, Nucleic Acids Res. 34 (2006)
5541–5551.
[65] Z. Wang, G.M. Jones, G. Prelich, Genetic analysis connects SLX5 and SLX8 to the
SUMO pathway in Saccharomyces cerevisiae, Genetics 172 (2006) 1499–1509.
[66] J.R. Mullen, S.J. Brill, Activation of the Slx5–Slx8 ubiquitin ligase by poly-small
ubiquitin-like modiﬁer conjugates, J. Biol. Chem. 283 (2008) 19912–19921.
[67] J.R. Mullen, V. Kaliraman, S.S. Ibrahim, S.J. Brill, Requirement for three novel protein
complexes in the absence of the Sgs1 DNA helicase in Saccharomyces cerevisiae, Ge-
netics 157 (2001) 103–118.
[68] T.M. Ashton, I.D. Hickson, Yeast as a model system to study RecQ helicase function,
DNA Repair (Amst) 9 (2010) 303–314.
[69] N.B. Larsen, I.D. Hickson, RecQ helicases: conserved guardians of genomic integrity,
Adv. Exp. Med. Biol. 767 (2013) 161–184.
[70] S. Gangloff, C. Soustelle, F. Fabre, Homologous recombination is responsible for cell
death in the absence of the Sgs1 and Srs2 helicases, Nat. Genet. 25 (2000) 192–194.
[71] A. De Muyt, L. Jessop, E. Kolar, A. Sourirajan, J. Chen, Y. Dayani, M. Lichten, BLM
helicase ortholog Sgs1 is a central regulator of meiotic recombination intermediate
metabolism, Mol. Cell 46 (2012) 43–53.
[72] K. Yamagata, J. Kato, A. Shimamoto, M. Goto, Y. Furuichi, H. Ikeda, Bloom's and
Werner's syndrome genes suppress hyperrecombination in yeast sgs1mutant: im-
plication for genomic instability in human diseases, Proc. Natl. Acad. Sci. U. S. A. 95
(1998) 8733–8738.
[73] J.R. Mullen, M. Das, S.J. Brill, Genetic evidence that polysumoylation bypasses the
need for a SUMO-targeted Ub ligase, Genetics 187 (2011) 73–87.
[74] J.A. Wohlschlegel, E.S. Johnson, S.I. Reed, J.R. Yates III, Global analysis of protein
sumoylation in Saccharomyces cerevisiae, J. Biol. Chem. 279 (2004) 45662–45668.
[75] O. Parnas, R. Amishay, B. Liefshitz, A. Zipin-Roitman, M. Kupiec, Elg1, the major
subunit of an alternative RFC complex, interacts with SUMO-processing proteins,
Cell Cycle 10 (2011) 2894–2903.
[76] M. Nie, A. Aslanian, J. Prudden, J. Heideker, A.A. Vashisht, J.A. Wohlschlegel, J.R. Yates
III, M.N. Boddy, Dual recruitment of Cdc48 (p97)–Ufd1–Npl4 ubiquitin-selective
segregase by small ubiquitin-like modiﬁer protein (SUMO) and ubiquitin in
SUMO-targeted ubiquitin ligase-mediated genome stability functions, J. Biol. Chem.
287 (2012) 29610–29619.
[77] S. Nagai, K. Dubrana, M. Tsai-Pﬂugfelder, M.B. Davidson, T.M. Roberts, G.W. Brown,
E. Varela, F. Hediger, S.M. Gasser, N.J. Krogan, Functional targeting of DNA damage
to a nuclear pore-associated SUMO-dependent ubiquitin ligase, Science 322
(2008) 597–602.
[78] L.A. van de Pasch, A.J. Miles, W. Nijenhuis, N.A. Brabers, D. van Leenen, P. Lijnzaad,
M.K. Brown, J. Ouellet, Y. Barral, G.J. Kops, F.C. Holstege, Centromere binding and a
conserved role in chromosome stability for SUMO-dependent ubiquitin ligases,
PLoS One 8 (2013) e65628.
[79] Z. Wang, G. Prelich, Quality control of a transcriptional regulator by
SUMO-targeted degradation, Mol. Cell. Biol. 29 (2009) 1694–1706.
[80] A. Ahner, X. Gong, B.Z. Schmidt, K.W. Peters, W.M. Rabeh, P.H. Thibodeau, G.L.
Lukacs, R.A. Frizzell, Small heat shock proteins target mutant cystic ﬁbrosis trans-
membrane conductance regulator for degradation via a small ubiquitin-like
modiﬁer-dependent pathway, Mol. Biol. Cell 24 (2013) 74–84.
[81] M.H. Tatham, I. Matic, M. Mann, R.T. Hay, Comparative proteomic analysis iden-
tiﬁes a role for SUMO in protein quality control, Sci. Signal. 4 (2011) rs4.
[82] Y. Xie, E.M. Rubenstein, T. Matt, M. Hochstrasser, SUMO-independent in vivo activ-
ity of a SUMO-targeted ubiquitin ligase toward a short-lived transcription factor,
Genes Dev. 24 (2010) 893–903.
[83] G.L. Moldovan, B. Pfander, S. Jentsch, PCNA, themaestro of the replication fork, Cell
129 (2007) 665–679.
[84] C. Hoege, B. Pfander, G.L. Moldovan, G. Pyrowolakis, S. Jentsch, RAD6-dependent
DNA repair is linked to modiﬁcation of PCNA by ubiquitin and SUMO, Nature
419 (2002) 135–141.
[85] P. Stelter, H.D. Ulrich, Control of spontaneous and damage-inducedmutagenesis by
SUMO and ubiquitin conjugation, Nature 425 (2003) 188–191.
[86] B. Pfander, G.L. Moldovan, M. Sacher, C. Hoege, S. Jentsch, SUMO-modiﬁed PCNA
recruits Srs2 to prevent recombination during S phase, Nature 436 (2005)
428–433.
[87] E. Papouli, S. Chen, A.A. Davies, D. Huttner, L. Krejci, P. Sung, H.D. Ulrich, Crosstalk
between SUMO and ubiquitin on PCNA is mediated by recruitment of the helicase
Srs2p, Mol. Cell 19 (2005) 123–133.
84 A.M. Sriramachandran, R.J. Dohmen / Biochimica et Biophysica Acta 1843 (2014) 75–85[88] P. Burkovics, M. Sebesta, A. Sisakova, N. Plault, V. Szukacsov, T. Robert, L. Pinter, V.
Marini, P. Kolesar, L. Haracska, S. Gangloff, L. Krejci, Srs2 mediates PCNA-SUMO-
dependent inhibition of DNA repair synthesis, EMBO J. 32 (2013) 742–755.
[89] J.L. Parker, H.D. Ulrich, A SUMO-interacting motif activates budding yeast
ubiquitin ligase Rad18 towards SUMO-modiﬁed PCNA, Nucleic Acids Res. 40
(2012) 11380–11388.
[90] A. Kosoy, T.M. Calonge, E.A. Outwin,M.J. O'Connell, Fission yeast Rnf4 homologs are
required for DNA repair, J. Biol. Chem. 282 (2007) 20388–20394.
[91] R. Steinacher, F. Osman, A. Lorenz, C. Bryer, M.C. Whitby, Slx8 removes
Pli1-dependent protein-SUMO conjugates including SUMOylated topoisomerase I
to promote genome stability, PLoS One 8 (2013) e71960.
[92] J. Heideker, J.J. Perry, M.N. Boddy, Genome stability roles of SUMO-targeted
ubiquitin ligases, DNA Repair (Amst) 8 (2009) 517–524.
[93] J. Heideker, J. Prudden, J.J. Perry, J.A. Tainer, M.N. Boddy, SUMO-targeted ubiquitin
ligase, Rad60, and Nse2 SUMO ligase suppress spontaneous Top1-mediated DNA
damage and genome instability, PLoS Genet. 7 (2011) e1001320.
[94] A.M. Moilanen, H. Poukka, U. Karvonen, M. Hakli, O.A. Janne, J.J. Palvimo, Identiﬁca-
tion of a novel RING ﬁnger protein as a coregulator in steroid receptor-mediated
gene transcription, Mol. Cell. Biol. 18 (1998) 5128–5139.
[95] C.W. Liew, H. Sun, T. Hunter, C.L. Day, RING domain dimerization is essential for
RNF4 function, Biochem. J. 431 (2010) 23–29.
[96] A. Plechanovova, E.G. Jaffray, S.A. McMahon, K.A. Johnson, I. Navratilova, J.H.
Naismith, R.T. Hay, Mechanism of ubiquitylation by dimeric RING ligase RNF4,
Nat. Struct. Mol. Biol. 18 (2011) 1052–1059.
[97] A. Plechanovova, E.G. Jaffray,M.H. Tatham, J.H. Naismith, R.T. Hay, Structure of a RING
E3 ligase and ubiquitin-loaded E2 primed for catalysis, Nature 489 (2012) 115–120.
[98] V. Lallemand-Breitenbach, J. Zhu, F. Puvion, M. Koken, N. Honore, A. Doubeikovsky,
E. Duprez, P.P. Pandolﬁ, E. Puvion, P. Freemont, H. de The, Role of promyelocytic
leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruit-
ment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation,
J. Exp. Med. 193 (2001) 1361–1371.
[99] X.W. Zhang, X.J. Yan, Z.R. Zhou, F.F. Yang, Z.Y.Wu, H.B. Sun,W.X. Liang, A.X. Song, V.
Lallemand-Breitenbach, M. Jeanne, Q.Y. Zhang, H.Y. Yang, Q.H. Huang, G.B. Zhou,
J.H. Tong, Y. Zhang, J.H. Wu, H.Y. Hu, H. de The, S.J. Chen, Z. Chen, Arsenic trioxide
controls the fate of the PML-RARalpha oncoprotein by directly binding PML, Sci-
ence 328 (2010) 240–243.
[100] D. Finley, Recognition and processing of ubiquitin-protein conjugates by the
proteasome, Annu. Rev. Biochem. 78 (2009) 477–513.
[101] M. Hakli, U. Karvonen, O.A. Janne, J.J. Palvimo, SUMO-1 promotes association of
SNURF (RNF4) with PML nuclear bodies, Exp. Cell Res. 304 (2005) 224–233.
[102] M.C. Geoffroy, E.G. Jaffray, K.J. Walker, R.T. Hay, Arsenic-induced SUMO-dependent
recruitment of RNF4 into PML nuclear bodies, Mol. Biol. Cell 21 (2010) 4227–4239.
[103] T.H. Shen, H.K. Lin, P.P. Scaglioni, T.M. Yung, P.P. Pandolﬁ, The mechanisms of
PML-nuclear body formation, Mol. Cell 24 (2006) 331–339.
[104] D.Y. Lin, Y.S. Huang, J.C. Jeng, H.Y. Kuo, C.C. Chang, T.T. Chao, C.C. Ho, Y.C. Chen, T.P.
Lin, H.I. Fang, C.C. Hung, C.S. Suen,M.J. Hwang, K.S. Chang, G.G.Maul, H.M. Shih, Role
of SUMO-interactingmotif inDaxx SUMOmodiﬁcation, subnuclear localization, and
repression of sumoylated transcription factors, Mol. Cell 24 (2006) 341–354.
[105] D. Mukhopadhyay, A. Arnaoutov, M. Dasso, The SUMO protease SENP6 is essential
for inner kinetochore assembly, J. Cell Biol. 188 (2010) 681–692.
[106] M. van Hagen, R.M. Overmeer, S.S. Abolvardi, A.C. Vertegaal, RNF4 and VHL regu-
late the proteasomal degradation of SUMO-conjugated Hypoxia-Inducible
Factor-2alpha, Nucleic Acids Res. 38 (2010) 1922–1931.
[107] B. Keith, R.S. Johnson, M.C. Simon, HIF1alpha and HIF2alpha: sibling rivalry in hyp-
oxic tumour growth and progression, Nat. Rev. Cancer 12 (2012) 9–22.
[108] J. Cheng, X. Kang, S. Zhang, E.T. Yeh, SUMO-speciﬁc protease 1 is essential for sta-
bilization of HIF1alpha during hypoxia, Cell 131 (2007) 584–595.
[109] Q. Cai, S.C. Verma, P. Kumar,M.Ma, E.S. Robertson, Hypoxia inactivates theVHL tumor
suppressor through PIASy-mediated SUMOmodiﬁcation, PLoS One 5 (2010) e9720.
[110] B. Guo, A.D. Sharrocks, Extracellular signal-regulated kinase mitogen-activated
protein kinase signaling initiates a dynamic interplay between sumoylation and
ubiquitination to regulate the activity of the transcriptional activator PEA3, Mol.
Cell. Biol. 29 (2009) 3204–3218.
[111] N. Martin, K. Schwamborn, V. Schreiber, A. Werner, C. Guillier, X.D. Zhang, O.
Bischof, J.S. Seeler, A. Dejean, PARP-1 transcriptional activity is regulated by
sumoylation upon heat shock, EMBO J. 28 (2009) 3534–3548.
[112] X.V. Hu, T.M. Rodrigues, H. Tao, R.K. Baker, L. Miraglia, A.P. Orth, G.E. Lyons, P.G.
Schultz, X. Wu, Identiﬁcation of RING ﬁnger protein 4 (RNF4) as a modulator of
DNA demethylation through a functional genomics screen, Proc. Natl. Acad. Sci.
U. S. A. 107 (2010) 15087–15092.
[113] H. Takahashi, S. Hatakeyama, H. Saitoh, K.I. Nakayama, Noncovalent SUMO-1 bind-
ing activity of thymine DNA glycosylase (TDG) is required for its SUMO-1 modiﬁ-
cation and colocalization with the promyelocytic leukemia protein, J. Biol. Chem.
280 (2005) 5611–5621.
[114] K.A. Fryrear, X. Guo, O. Kerscher, O.J. Semmes, The SUMO-targeted ubiquitin ligase
RNF4 regulates the localization and function of the HTLV-1 oncoprotein Tax, Blood
119 (2012) 1173–1181.
[115] M.H. Tatham, A. Plechanovova, E.G. Jaffray, H. Salmen, R.T. Hay, Ube2W conjugates
ubiquitin to alpha-amino groups of protein N-termini, Biochem. J. 453 (2013) 137–145.
[116] D. Komander,M. Rape, The ubiquitin code, Annu. Rev. Biochem. 81 (2012) 203–229.
[117] Y. Yin, A. Seifert, J.S. Chua, J.F. Maure, F. Golebiowski, R.T. Hay, SUMO-targeted
ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA dam-
age, Genes Dev. 26 (2012) 1196–1208.
[118] A. Ahner, X. Gong, B.Z. Schmidt, K.W. Peters, W.M. Rabeh, P.H. Thibodeau, G.L.
Lukacs, R.A. Frizzell, Small heat shock proteins target mutant CFTR for degradation
via a SUMO-dependent pathway, Mol. Biol. Cell 24 (2013) 74–84.[119] H. Sun, T. Hunter, PolySUMO-binding proteins identiﬁed through a string search, J.
Biol. Chem. 287 (2012) 42071–42083.
[120] Y. Inoue, T. Imamura, Regulation of TGF-beta family signaling by E3 ubiquitin li-
gases, Cancer Sci. 99 (2008) 2107–2112.
[121] J.S. Kang, E.F. Saunier, R.J. Akhurst, R. Derynck, The type I TGF-beta receptor is co-
valentlymodiﬁed and regulated by sumoylation, Nat. Cell Biol. 10 (2008) 654–664.
[122] M.J. Kim, I.V. Chia, F. Costantini, SUMOylation target sites at the C terminus protect
Axin fromubiquitination andconfer protein stability, FASEB J. 22 (2008) 3785–3794.
[123] P.S. Lee, C. Chang, D. Liu, R. Derynck, Sumoylation of Smad4, the common Smad
mediator of transforming growth factor-beta family signaling, J. Biol. Chem. 278
(2003) 27853–27863.
[124] J. Long, G. Wang, D. He, F. Liu, Repression of Smad4 transcriptional activity by
SUMO modiﬁcation, Biochem. J. 379 (2004) 23–29.
[125] S. Imoto, K. Sugiyama, R. Muromoto, N. Sato, T. Yamamoto, T. Matsuda, Regulation
of transforming growth factor-beta signaling by protein inhibitor of activated
STAT, PIASy through Smad3, J. Biol. Chem. 278 (2003) 34253–34258.
[126] Y. Erker, H. Neyret-Kahn, J.S. Seeler, A. Dejean, A. Atﬁ, L. Levy, Arkadia, a novel
SUMO-targeted ubiquitin ligase involved in PML degradation, Mol. Cell. Biol. 33
(2013) 2136–2177.
[127] A. Fischer, M. Gessler, Delta-Notch - and then? Protein interactions and proposed
modes of repression by Hes and Hey bHLH factors. Nucleic Acids Res. 35 (2007)
4583–4596.
[128] M. Abed, K.C. Barry, D. Kenyagin, B. Koltun, T.M. Phippen, J.J. Delrow, S.M.
Parkhurst, A. Orian, Degringolade, a SUMO-targeted ubiquitin ligase, inhibits
Hairy/Groucho-mediated repression, EMBO J. 30 (2011) 1289–1301.
[129] K.C. Barry, M. Abed, D. Kenyagin, T.R. Werwie, O. Boico, A. Orian, S.M. Parkhurst,
The Drosophila STUbL protein Degringolade limits HES functions during embryo-
genesis, Development 138 (2011) 1759–1769.
[130] M. Abed, E. Bitman-Lotan, A. Orian, A ﬂy view of a SUMO-targeted ubiquitin ligase,
Fly (Austin) 5 (2011).
[131] P. Wimmer, S. Schreiner, T. Dobner, Human pathogens and the host cell
SUMOylation system, J. Virol. 86 (2012) 642–654.
[132] C. Boutell, R.D. Everett, Regulation of alphaherpesvirus infections by the ICP0 fam-
ily of proteins, J. Gen. Virol. 94 (2013) 465–481.
[133] R.D. Everett, C. Boutell, B.G. Hale, Interplay between viruses and host sumoylation
pathways, Nat. Rev. Microbiol. 11 (2013) 400–411.
[134] D. Cuchet-Lourenco, C. Boutell, V. Lukashchuk, K. Grant, A. Sykes, J. Murray, A. Orr,
R.D. Everett, SUMO pathway dependent recruitment of cellular repressors to her-
pes simplex virus type 1 genomes, PLoS Pathog. 7 (2011) e1002123.
[135] C. Boutell, D. Cuchet-Lourenco, E. Vanni, A. Orr,M. Glass, S.McFarlane, R.D. Everett, A
viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase ac-
tivity that counteracts intrinsic antiviral defence, PLoS Pathog. 7 (2011) e1002245.
[136] C. Boutell, A. Orr, R.D. Everett, PML residue lysine 160 is required for the degrada-
tion of PML induced by herpes simplex virus type 1 regulatory protein ICP0, J. Virol.
77 (2003) 8686–8694.
[137] C.L. Wilcox, R.L. Smith, R.D. Everett, D. Mysofski, The herpes simplex virus type 1
immediate-early protein ICP0 is necessary for the efﬁcient establishment of latent
infection, J. Virol. 71 (1997) 6777–6785.
[138] C. Boutell, R.D. Everett, The herpes simplex virus type 1 (HSV-1) regulatory protein
ICP0 interacts with and Ubiquitinates p53, J. Biol. Chem. 278 (2003) 36596–36602.
[139] C. Boutell, M. Canning, A. Orr, R.D. Everett, Reciprocal activities between herpes sim-
plex virus type 1 regulatory protein ICP0, a ubiquitin E3 ligase, andubiquitin-speciﬁc
protease USP7, J. Virol. 79 (2005) 12342–12354.
[140] M.S. Chaurushiya, C.E. Lilley, A. Aslanian, J. Meisenhelder, D.C. Scott, S. Landry, S.
Ticau, C. Boutell, J.R. Yates III, B.A. Schulman, T. Hunter, M.D. Weitzman, Viral E3
ubiquitin ligase-mediated degradation of a cellular E3: viral mimicry of a cellular
phosphorylation mark targets the RNF8 FHA domain, Mol. Cell 46 (2012) 79–90.
[141] M.S. Walters, C.A. Kyratsous, S.J. Silverstein, The RING ﬁnger domain of
Varicella-Zoster virus ORF61p has E3 ubiquitin ligase activity that is essential
for efﬁcient autoubiquitination and dispersion of Sp100-containing nuclear
bodies, J. Virol. 84 (2010) 6861–6865.
[142] C.A. Kyratsous, M.S. Walters, C.A. Panagiotidis, S.J. Silverstein, Complementation of
a herpes simplex virus ICP0 null mutant by varicella-zoster virus ORF61p, J. Virol.
83 (2009) 10637–10643.
[143] L. Wang, S.L. Oliver, M. Sommer, J. Rajamani, M. Reichelt, A.M. Arvin, Disruption of
PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required
for varicella-zoster virus pathogenesis in skin, PLoS Pathog. 7 (2011) e1002157.
[144] I. Schwienhorst, E.S. Johnson, R.J. Dohmen, SUMO conjugation and deconjugation,
Mol. Gen. Genet. 263 (2000) 771–786.
[145] S.J. Li, M. Hochstrasser, The yeast ULP2 (SMT4) gene encodes a novel protease spe-
ciﬁc for the ubiquitin-like Smt3 protein, Mol. Cell. Biol. 20 (2000) 2367–2377.
[146] D. Maeda, M. Seki, F. Onoda, D. Branzei, Y. Kawabe, T. Enomoto, Ubc9 is required for
damage-tolerance and damage-induced interchromosomal homologous recombi-
nation in S. cerevisiae, DNA Repair (Amst) 3 (2004) 335–341.
[147] X. Zhao, G. Blobel, A SUMO ligase is part of a nuclear multiprotein complex that af-
fects DNA repair and chromosomal organization, Proc. Natl. Acad. Sci. U. S. A. 102
(2005) 4777–4782.
[148] D. Branzei, J. Sollier, G. Liberi, X. Zhao, D. Maeda, M. Seki, T. Enomoto, K. Ohta, M.
Foiani, Ubc9- and mms21-mediated sumoylation counteracts recombinogenic
events at damaged replication forks, Cell 127 (2006) 509–522.
[149] H.R. Silver, J.A. Nissley, S.H. Reed, Y.M. Hou, E.S. Johnson, A role for SUMO in nucle-
otide excision repair, DNA Repair (Amst) 10 (2011) 1243–1251.
[150] S. Bergink, S. Jentsch, Principles of ubiquitin and SUMO modiﬁcations in DNA re-
pair, Nature 458 (2009) 461–467.
[151] H.D. Ulrich, H.Walden, Ubiquitin signalling in DNA replication and repair, Nat. Rev.
Mol. Cell Biol. 11 (2010) 479–489.
85A.M. Sriramachandran, R.J. Dohmen / Biochimica et Biophysica Acta 1843 (2014) 75–85[152] H.D. Ulrich, Ubiquitin and SUMO in DNA repair at a glance, J. Cell Sci. 125 (2012)
249–254.
[153] S.P. Jackson, D. Durocher, Regulation of DNA damage responses by ubiquitin and
SUMO, Mol. Cell 49 (2013) 795–807.
[154] C.A. Cremona, P. Sarangi, Y. Yang, L.E. Hang, S. Rahman, X. Zhao, Extensive DNA
damage-induced sumoylation contributes to replication and repair and acts in ad-
dition to the mec1 checkpoint, Mol. Cell 45 (2012) 422–432.
[155] J. Schimmel, K.M. Larsen, I. Matic, M. van Hagen, J. Cox, M. Mann, J.S. Andersen,
A.C. Vertegaal, The ubiquitin–proteasome system is a key component of the
SUMO-2/3 cycle, Mol. Cell Proteomics 7 (2008) 2107–2122.
[156] Y. Galanty, R. Belotserkovskaya, J. Coates, S.P. Jackson, RNF4, a SUMO-targeted
ubiquitin E3 ligase, promotes DNA double-strand break repair, Genes Dev. 26
(2012) 1179–1195.
[157] K. Luo, H. Zhang, L. Wang, J. Yuan, Z. Lou, Sumoylation of MDC1 is important for
proper DNA damage response, EMBO J. 31 (2012) 3008–3019.
[158] R. Vyas, R. Kumar, F. Clermont, A. Helfricht, P. Kalev, P. Sotiropoulou, I.A. Hendriks,
E. Radaelli, T. Hochepied, C. Blanpain, A. Sablina, H. van Attikum, J.V. Olsen, A.G.
Jochemsen, A.C. Vertegaal, J.C. Marine, RNF4 is required for DNA double-strand
break repair in vivo, Cell Death Differ. 20 (2013) 490–502.
[159] N.P. Dantuma, T. Hoppe, Growing sphere of inﬂuence: Cdc48/p97 orchestrates
ubiquitin-dependent extraction from chromatin, Trends Cell Biol. 22 (2012)
483–491.[160] C.M. Guzzo, C.E. Berndsen, J. Zhu, V. Gupta, A. Datta, R.A. Greenberg, C. Wolberger,
M.J. Matunis, RNF4-dependent hybrid SUMO-ubiquitin chains are signals for
RAP80 and thereby mediate the recruitment of BRCA1 to sites of DNA damage,
Sci. Signal. 5 (2012) ra88.
[161] X. Hu, A. Paul, B. Wang, Rap80 protein recruitment to DNA double-strand breaks
requires binding to both small ubiquitin-like modiﬁer (SUMO) and ubiquitin con-
jugates, J. Biol. Chem. 287 (2012) 25510–25519.
[162] C.M. Guzzo, M.J. Matunis, Expanding SUMO and ubiquitin-mediated signaling
through hybrid SUMO-ubiquitin chains and their receptors, Cell Cycle 12 (2013)
1015–1017.
[163] J.R. Mullen, C.F. Chen, S.J. Brill, Wss1 is a SUMO-dependent isopeptidase that inter-
acts genetically with the Slx5–Slx8 SUMO-targeted ubiquitin ligase, Mol. Cell. Biol.
30 (2010) 3737–3748.
[164] M. Ghislain, R.J. Dohmen, F. Levy, A. Varshavsky, Cdc48p interacts with Ufd3p, a
WD repeat protein required for ubiquitin-mediated proteolysis in Saccharomyces
cerevisiae, EMBO J. 15 (1996) 4884–4899.
[165] A. Stolz, W. Hilt, A. Buchberger, D.H. Wolf, Cdc48: a powermachine in protein deg-
radation, Trends Biochem. Sci. 36 (2011) 515–523.
[166] J.M. Danielsen, K.B. Sylvestersen, S. Bekker-Jensen, D. Szklarczyk, J.W. Poulsen,
H. Horn, L.J. Jensen, N. Mailand, M.L. Nielsen, Mass spectrometric analysis of ly-
sine ubiquitylation reveals promiscuity at site level, Mol. Cell Proteomics 10
(2011)(M110 003590).
